IBOV 174,041.95 ▼ 1.52% IPSA 10,950.74 ▲ 0.31% IPC MEX 66,383.68 ▲ 0.21% MERVAL 3,283,854 ▼ 1.07% COLCAP 2,274.53 ▼ 0.38% BVL PERÚ 58,287.01 — — USD/BRL5.08▼ 0.24% USD/MXN17.49▲ 0.09% USD/CLP 948.45 — 0.00% USD/COP3,218▲ 0.16% USD/PEN3.40▲ 0.13% USD/ARS1,496▲ 0.47% USD/UYU40.14▲ 1.38% USD/PYG6,022▲ 1.26% USD/BOB11.18▲ 4.51% USD/DOP57.99▼ 0.28% USD/CRC449.17▲ 1.76% USD/GTQ7.63▲ 2.33% USD/HNL26.75▲ 0.82% USD/NIO36.62▲ 0.51% USD/VES740.37▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.29▲ 0.11% USD/TTD6.71▲ 0.92% EUR/BRL5.78▲ 0.08% BRENT 96.78 ▼ 3.88% WTI 89.31 ▼ 3.12% IRON ORE 161.91 — — COPPER 6.36 ▲ 0.83% GOLD 4,071 ▲ 0.60% SILVER 58.91 ▲ 1.92% SOY 1,254 ▲ 1.29% CORN 487.25 ▲ 5.01% WHEAT 678.00 ▼ 2.62% COFFEE 298.25 ▼ 3.60% SUGAR 14.76 ▲ 0.48% ORANGE JUICE 142.65 ▼ 2.83% COTTON 79.89 ▲ 0.06% COCOA 5,467 ▲ 3.13% BEEF 222.50 ▼ 1.29% CATTLE 341.45 ▼ 0.68% LITHIUM 67.81 ▼ 1.75% PETR4 42.21 ▼ 1.72% VALE3 75.24 ▼ 0.58% ITUB4 42.10 ▼ 1.08% BBDC4 18.48 ▼ 1.28% ABEV3 15.64 ▼ 1.76% BBAS3 20.35 ▼ 2.77% B3SA3 15.44 ▼ 1.34% WEGE3 45.99 ▲ 0.70% PRIO3 58.82 ▼ 2.84% SUZB3 41.84 ▼ 1.39% RENT3 36.89 ▼ 0.67% AZZA3 16.65 ▼ 2.35% CSAN3 3.80 ▼ 2.56% RAIZ4 0.26 ▼ 3.70% PCAR3 2.79 ▼ 2.79% GMAT3 3.79 ▼ 2.07% PSSA3 54.78 ▼ 0.72% CVCB3 1.34 ▲ 2.29% POSI3 3.55 ▼ 3.27% SLCE3 13.64 ▼ 0.94% NATU3 8.38 ▼ 2.10% RANI3 7.95 ▲ 0.25% CSNA3 5.36 ▲ 1.13% CMIN3 5.69 ▼ 2.40% USIM5 8.48 ▼ 0.12% GGBR4 24.26 ▲ 0.83% ENEV3 24.90 ▼ 3.11% CPFE3 45.09 ▼ 2.44% CMIG4 10.98 ▼ 1.88% EQTL3 38.34 ▼ 1.74% LREN3 13.27 ▼ 0.75% VIVT3 35.47 ▲ 2.22% RAIL3 13.57 ▼ 2.79% KLABIN 17.52 ▼ 0.79% RAIA DROGASIL 17.98 ▼ 1.15% RDOR3 33.38 ▼ 0.86% HAPV3 9.92 ▼ 5.25% FLRY3 16.26 ▼ 1.93% SMTO3 15.05 ▼ 4.20% UGPA3 32.71 ▼ 2.04% VBBR3 35.10 ▼ 1.40% BBSE3 41.49 ▼ 2.15% BPAC11 54.67 ▼ 2.90% CURY3 29.35 ▼ 0.91% AERI3 2.04 ▲ 0.99% VIVARA 21.42 ▼ 0.14% COMPASS 24.76 ▼ 1.28% VAMOS 3.15 ▼ 1.87% SANB11 26.34 ▼ 1.09% ASAI3 7.85 ▼ 2.12% SBSP3 28.38 ▼ 1.29% WALMEX 48.00 ▲ 1.39% GMEXICO 207.28 ▼ 0.94% FEMSA 221.92 ▼ 0.19% CEMEX 21.18 ▼ 1.40% GFNORTE 193.04 ▲ 2.00% BIMBO 58.26 ▼ 1.39% TELEVISA 9.73 ▼ 0.61% AMX 22.80 ▲ 0.18% GAP 377.44 ▲ 0.26% ASUR 267.76 — 0.00% OMA 226.14 ▼ 0.51% KOF 179.29 ▼ 0.23% GRUMA 268.70 ▼ 0.09% KIMBER 39.70 ▲ 1.10% SQM-B 65,350 ▼ 0.23% COPEC 6,330 ▲ 1.12% BSANTANDER 79.32 ▼ 0.85% FALABELLA 5,990 ▼ 1.12% ENELAM 85.49 ▲ 0.58% CENCOSUD 1,958 ▼ 0.51% CMPC 1,025 ▼ 2.47% BANCO CHILE 193.10 ▲ 1.25% LATAM AIR 23.88 ▲ 1.62% YPF 82,000 ▼ 0.58% GGAL 7,890 ▼ 0.69% PAMPA 5,515 ▼ 2.04% TXAR 675.00 ▼ 0.74% ALUAR 972.00 ▼ 1.07% TGS 9,765 ▼ 2.30% CEPU 2,365 ▼ 2.27% MIRGOR 16,525 ▼ 1.20% COME 42.41 ▼ 0.28% LOMA NEGRA 3,623 ▼ 3.78% BYMA 299.75 ▲ 2.48% TELECOM ARG 4,380 ▲ 1.27% ECOPETROL 16.01 ▼ 1.96% BANCOLOMBIA 86.01 ▼ 0.90% GRUPO AVAL 4.79 ▼ 3.04% CREDICORP 388.77 ▲ 0.29% SOUTHERN COPPER 179.29 ▼ 1.61% BUENAVENTURA 30.91 ▼ 1.31% MERCADOLIBRE 1,801 ▲ 0.15% NUBANK 14.09 ▼ 0.70% XP 16.69 ▼ 0.83% PAGSEGURO 9.20 ▼ 2.75% STONE 10.76 ▼ 2.00% GLOBANT 31.30 ▲ 2.25% TECNOGLASS 45.30 ▲ 3.57% GAP AIRPORT 216.28 ▲ 0.39% ASUR 267.76 — 0.00% OMA AIRPORT 103.43 — 0.00% AMX ADR 26.01 ▲ 0.23% FEMSA ADR 127.12 ▲ 0.03% CEMEX ADR 12.06 ▼ 1.63% PETROBRAS ADR 18.77 ▼ 1.21% VALE ADR 14.79 ▼ 0.27% ITAU ADR 8.28 ▼ 0.84% SANTANDER BR 5.30 ▼ 1.21% AMBEV ADR 3.06 ▼ 0.97% CSN 1.08 ▲ 1.89% GERDAU 4.81 ▲ 0.84% LATAM ADR 50.15 — 0.00% BTC 64,439 ▲ 0.53% ETH 1,878 ▲ 0.95% SOL 74.81 ▲ 1.26% XRP 1.10 ▲ 0.75% BNB 569.83 ▲ 0.97% ADA 0.17 ▲ 0.84% DOGE 0.07 ▲ 4.17% AVAX 6.76 ▲ 7.36% LINK 8.40 ▲ 0.85% DOT 0.82 ▲ 1.45% LTC 46.72 ▲ 0.85% BCH 209.48 ▼ 0.52% TRX 0.33 ▲ 0.13% XLM 0.18 ▼ 0.28% HBAR 0.07 ▼ 1.00% NEAR 1.79 ▼ 0.66% ATOM 1.38 ▼ 0.54% AAVE 92.60 ▼ 0.48% SELIC 14.25% BRKM5 6.10 ▼ 1.13% EMBRAER 82.50 ▼ 1.08% EMBRAER ADR 64.93 ▼ 0.82% JBS 12.28 ▲ 1.24% JBS BDR 62.04 ▲ 0.36% MBRF3 14.84 ▼ 4.81% MBRFY 2.94 ▼ 0.34% INTER 5.29 ▼ 3.11% EGX 53,932 ▼ 0.11% USD/ZAR16.82▲ 0.03% USD/NGN1,363▼ 0.44% NIKKEI 64,611 ▼ 2.73% CSI300 4,649 ▼ 1.67% HSI 24,963 ▼ 0.98% NIFTY 23,767 ▼ 0.43% KOSPI 6,691 ▼ 5.72% JCI 6,196 ▼ 1.88% USD/JPY163.79▼ 0.04% USD/CNY6.76▼ 0.15% DAX 25,099 ▲ 1.36% CAC 8,372 ▲ 0.88% FTSE 10,736 ▲ 0.91% MIB 51,802 ▲ 0.95% IBEX 19,585 ▲ 1.65% STOXX 644.51 ▲ 0.82% EUR/USD1.14▼ 0.02% GBP/USD1.33▲ 0.06% SPX 7,412 ▲ 0.05% DJI 51,947 ▲ 0.46% NDX 28,128 ▼ 1.15% RUT 2,930 ▼ 0.35% TSX 35,369 ▲ 0.50% VIX 18.58 ▼ 0.64% USD/CAD1.41— 0.00% US10Y 4.6790 ▼ 0.51% IBOV 174,041.95 ▼ 1.52% IPSA 10,950.74 ▲ 0.31% IPC MEX 66,383.68 ▲ 0.21% MERVAL 3,283,854 ▼ 1.07% COLCAP 2,274.53 ▼ 0.38% BVL PERÚ 58,287.01 — — USD/BRL 5.08 ▼ 0.24% USD/MXN 17.49 ▲ 0.09% USD/CLP 948.45 — 0.00% USD/COP 3,218 ▲ 0.16% USD/PEN 3.40 ▲ 0.13% USD/ARS 1,496 ▲ 0.47% USD/UYU 40.14 ▲ 1.38% USD/PYG 6,022 ▲ 1.26% USD/BOB 11.18 ▲ 4.51% USD/DOP 57.99 ▼ 0.28% USD/CRC 449.17 ▲ 1.76% USD/GTQ 7.63 ▲ 2.33% USD/HNL 26.75 ▲ 0.82% USD/NIO 36.62 ▲ 0.51% USD/VES 740.37 ▲ 0.46% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.29 ▲ 0.08% USD/TTD 6.71 ▲ 0.68% EUR/BRL 5.78 ▲ 0.08% BRENT 96.78 ▼ 3.88% WTI 89.31 ▼ 3.12% IRON ORE 161.91 — — COPPER 6.36 ▲ 0.83% GOLD 4,071 ▲ 0.60% SILVER 58.91 ▲ 1.92% SOY 1,254 ▲ 1.29% CORN 487.25 ▲ 5.01% WHEAT 678.00 ▼ 2.62% COFFEE 298.25 ▼ 3.60% SUGAR 14.76 ▲ 0.48% ORANGE JUICE 142.65 ▼ 2.83% COTTON 79.89 ▲ 0.06% COCOA 5,467 ▲ 3.13% BEEF 222.50 ▼ 1.29% CATTLE 341.45 ▼ 0.68% LITHIUM 67.81 ▼ 1.75% PETR4 42.21 ▼ 1.72% VALE3 75.24 ▼ 0.58% ITUB4 42.10 ▼ 1.08% BBDC4 18.48 ▼ 1.28% ABEV3 15.64 ▼ 1.76% BBAS3 20.35 ▼ 2.77% B3SA3 15.44 ▼ 1.34% WEGE3 45.99 ▲ 0.70% PRIO3 58.82 ▼ 2.84% SUZB3 41.84 ▼ 1.39% RENT3 36.89 ▼ 0.67% AZZA3 16.65 ▼ 2.35% CSAN3 3.80 ▼ 2.56% RAIZ4 0.26 ▼ 3.70% PCAR3 2.79 ▼ 2.79% GMAT3 3.79 ▼ 2.07% PSSA3 54.78 ▼ 0.72% CVCB3 1.34 ▲ 2.29% POSI3 3.55 ▼ 3.27% SLCE3 13.64 ▼ 0.94% NATU3 8.38 ▼ 2.10% RANI3 7.95 ▲ 0.25% CSNA3 5.36 ▲ 1.13% CMIN3 5.69 ▼ 2.40% USIM5 8.48 ▼ 0.12% GGBR4 24.26 ▲ 0.83% ENEV3 24.90 ▼ 3.11% CPFE3 45.09 ▼ 2.44% CMIG4 10.98 ▼ 1.88% EQTL3 38.34 ▼ 1.74% LREN3 13.27 ▼ 0.75% VIVT3 35.47 ▲ 2.22% RAIL3 13.57 ▼ 2.79% KLABIN 17.52 ▼ 0.79% RAIA DROGASIL 17.98 ▼ 1.15% RDOR3 33.38 ▼ 0.86% HAPV3 9.92 ▼ 5.25% FLRY3 16.26 ▼ 1.93% SMTO3 15.05 ▼ 4.20% UGPA3 32.71 ▼ 2.04% VBBR3 35.10 ▼ 1.40% BBSE3 41.49 ▼ 2.15% BPAC11 54.67 ▼ 2.90% CURY3 29.35 ▼ 0.91% AERI3 2.04 ▲ 0.99% VIVARA 21.42 ▼ 0.14% COMPASS 24.76 ▼ 1.28% VAMOS 3.15 ▼ 1.87% SANB11 26.34 ▼ 1.09% ASAI3 7.85 ▼ 2.12% SBSP3 28.38 ▼ 1.29% WALMEX 48.00 ▲ 1.39% GMEXICO 207.28 ▼ 0.94% FEMSA 221.92 ▼ 0.19% CEMEX 21.18 ▼ 1.40% GFNORTE 193.04 ▲ 2.00% BIMBO 58.26 ▼ 1.39% TELEVISA 9.73 ▼ 0.61% AMX 22.80 ▲ 0.18% GAP 377.44 ▲ 0.26% ASUR 267.76 — 0.00% OMA 226.14 ▼ 0.51% KOF 179.29 ▼ 0.23% GRUMA 268.70 ▼ 0.09% KIMBER 39.70 ▲ 1.10% SQM-B 65,350 ▼ 0.23% COPEC 6,330 ▲ 1.12% BSANTANDER 79.32 ▼ 0.85% FALABELLA 5,990 ▼ 1.12% ENELAM 85.49 ▲ 0.58% CENCOSUD 1,958 ▼ 0.51% CMPC 1,025 ▼ 2.47% BANCO CHILE 193.10 ▲ 1.25% LATAM AIR 23.88 ▲ 1.62% YPF 82,000 ▼ 0.58% GGAL 7,890 ▼ 0.69% PAMPA 5,515 ▼ 2.04% TXAR 675.00 ▼ 0.74% ALUAR 972.00 ▼ 1.07% TGS 9,765 ▼ 2.30% CEPU 2,365 ▼ 2.27% MIRGOR 16,525 ▼ 1.20% COME 42.41 ▼ 0.28% LOMA NEGRA 3,623 ▼ 3.78% BYMA 299.75 ▲ 2.48% TELECOM ARG 4,380 ▲ 1.27% ECOPETROL 16.01 ▼ 1.96% BANCOLOMBIA 86.01 ▼ 0.90% GRUPO AVAL 4.79 ▼ 3.04% CREDICORP 388.77 ▲ 0.29% SOUTHERN COPPER 179.29 ▼ 1.61% BUENAVENTURA 30.91 ▼ 1.31% MERCADOLIBRE 1,801 ▲ 0.15% NUBANK 14.09 ▼ 0.70% XP 16.69 ▼ 0.83% PAGSEGURO 9.20 ▼ 2.75% STONE 10.76 ▼ 2.00% GLOBANT 31.30 ▲ 2.25% TECNOGLASS 45.30 ▲ 3.57% GAP AIRPORT 216.28 ▲ 0.39% ASUR 267.76 — 0.00% OMA AIRPORT 103.43 — 0.00% AMX ADR 26.01 ▲ 0.23% FEMSA ADR 127.12 ▲ 0.03% CEMEX ADR 12.06 ▼ 1.63% PETROBRAS ADR 18.77 ▼ 1.21% VALE ADR 14.79 ▼ 0.27% ITAU ADR 8.28 ▼ 0.84% SANTANDER BR 5.30 ▼ 1.21% AMBEV ADR 3.06 ▼ 0.97% CSN 1.08 ▲ 1.89% GERDAU 4.81 ▲ 0.84% LATAM ADR 50.15 — 0.00% BTC 64,439 ▲ 0.53% ETH 1,878 ▲ 0.95% SOL 74.81 ▲ 1.26% XRP 1.10 ▲ 0.75% BNB 569.83 ▲ 0.97% ADA 0.17 ▲ 0.84% DOGE 0.07 ▲ 4.17% AVAX 6.76 ▲ 7.36% LINK 8.40 ▲ 0.85% DOT 0.82 ▲ 1.45% LTC 46.72 ▲ 0.85% BCH 209.48 ▼ 0.52% TRX 0.33 ▲ 0.13% XLM 0.18 ▼ 0.28% HBAR 0.07 ▼ 1.00% NEAR 1.79 ▼ 0.66% ATOM 1.38 ▼ 0.54% AAVE 92.60 ▼ 0.48% SELIC 14.25% BRKM5 6.10 ▼ 1.13% EMBRAER 82.50 ▼ 1.08% EMBRAER ADR 64.93 ▼ 0.82% JBS 12.28 ▲ 1.24% JBS BDR 62.04 ▲ 0.36% MBRF3 14.84 ▼ 4.81% MBRFY 2.94 ▼ 0.34% INTER 5.29 ▼ 3.11% EGX 53,932 ▼ 0.11% USD/ZAR 16.82 ▲ 0.04% USD/NGN 1,363 ▼ 0.24% NIKKEI 64,611 ▼ 2.73% CSI300 4,649 ▼ 1.67% HSI 24,963 ▼ 0.98% NIFTY 23,767 ▼ 0.43% KOSPI 6,691 ▼ 5.72% JCI 6,196 ▼ 1.88% USD/JPY 163.79 ▲ 0.02% USD/CNY 6.7617 ▼ 0.07% DAX 25,099 ▲ 1.36% CAC 8,372 ▲ 0.88% FTSE 10,736 ▲ 0.91% MIB 51,802 ▲ 0.95% IBEX 19,585 ▲ 1.65% STOXX 644.51 ▲ 0.82% EUR/USD 1.1375 ▼ 0.06% GBP/USD 1.3321 ▲ 0.04% SPX 7,412 ▲ 0.05% DJI 51,947 ▲ 0.46% NDX 28,128 ▼ 1.15% RUT 2,930 ▼ 0.35% TSX 35,369 ▲ 0.50% VIX 18.58 ▼ 0.64% USD/CAD 1.4092 ▲ 0.09% US10Y 4.6790 ▼ 0.51%
since 2009
Sunday, July 26, 2026

Brazil Life & Society

Hospitalizations for SARS Double in Brazil, Exerting Pressure on National Health System

By · April 1, 2020 · 5 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – The number of people hospitalized for Severe Acute Respiratory Syndrome (SARS), a complication caused both by influenza viruses already known in Brazil and the novel coronavirus, has doubled this year. The number of hospitalizations in the country has reached 16,879, compared to 7,761 during the same period last year.

But only four percent of these cases (757 patients) tested positive for the Covid-19, according to the Ministry of Health, which did not report how many others tested positive for other types of flu or how many were tested in total.

Given the shortage of tests in the country, even among the severe cases – only those are now being tested due to the need to ration materials – the data are an indication that the number of infections with coronavirus may be even higher than the 4,579 cases and 159 confirmed deaths by last Monday.

Moreover, they point to the “perfect storm” that is forming in the country’s health network, according to warnings made by the Ministry itself: the current system is already overloaded not only by the aggressive Covid-19, but also by other viruses, such as H1N1, which terrorized the world for its high mortality rate in 2009.

The number of people hospitalized for Severe Acute Respiratory Syndrome (SARS), a complication caused both by influenza viruses already known in Brazil and the novel coronavirus, has doubled this year. (Photo internet reproduction)
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

As there is immunization for the other diseases, the portfolio advanced the vaccination campaign, which began for the elderly last week and runs until May for risk groups.

Hospitalizations for SARS increased exponentially this March, about two weeks after the first case of Covid-19 was confirmed in Brazil on March 25th (14 days is the incubation limit for the virus).

This increase in demand in health care facilities – an important factor in the equation about the overload in the hospital network and the risk of a collapse of the health system – raises two scenarios: either there is an unbridled increase of Influenza and other flu viruses in the country, or a massive part of this demand comes from the coronavirus: in this case, the testing shortage conceals the real impacts of Covid-19 on the health system.

“The strongest assumption is that the increase is due to the coronavirus,” says researcher Daniel Vilella, who regularly monitors the flu in Brazil through Fiocruz, using the same system as the data submitted by the Ministry of Health.

He explains that the Influenza curve, for instance, has a seasonal pattern and usually worsens in winter. In some years, this curve begins to grow a little earlier. “This year, the curve was higher since the start of the year. But over the past three weeks, this increase has been much greater and is consistent with the sustained transmission of coronavirus in Brazil,” adds Vilella.

Another clue on the impact of the coronavirus in this hospitalization report pointed out by the researcher concerns the age group of patients with severe acute respiratory syndrome.

“Typically, SARS has been more frequent in the 0 to 4 year-old range. But in recent weeks, it has been more frequent for individuals in the 60+ age group,” he explains. People over 60 are statistically more likely to develop a more severe case of Covid-19, according to experts.

The cases of severe acute respiratory syndrome are accounted for and the patients’ samples are collected and sent to specific laboratories to determine the cause. Initially, tests are conducted for influenza A, B and other viruses. If these are negative, the protocol is to conduct the specific test for the coronavirus.

The Ministry of Health has so far failed to report the percentage of patients hospitalized for severe acute respiratory syndrome that was actually tested for Covid-19. The country faces difficulties both with the global shortage of tests and the delay in their processing. There are reports of delays of up to ten days for the result, which also influences the final data.

“The protocol is to test, but that’s not comprehensive. It may end without conclusions,” says Daniel Vilella, in reference to the mention in the system of cases whose causes are left unidentified. “The increase is a warning for us to expand our testing capacity,” he says.

The Ministry of Health is trying to work on this, amid a worldwide limitation of testing. It has said in press conferences that the country can currently process 6,700 daily coronavirus tests, but that it would need to achieve 30,000 to 50,000 tests per day. Health officials claim they will probably not reach that target, since although there are resources, but there are not enough test suppliers.

However, the government says it will increase capacity with more laboratory tests and a rapid (less conclusive) test support, but they may be used in screening.

Infectologist Rosana Paiva believes that the exponential increase in hospitalizations for severe acute respiratory syndrome is an important reflection of the presence of the coronavirus in Brazil, but considers that other factors may influence this account, related to the protocols at the health facilities.

Since Covid-19 is a new disease and quickly develops into severe cases, both the population and health professionals would be doubling the care for suspected cases – which also include flu cases, since the initial symptoms are similar.

Paiva says there is a greater search for patients with some respiratory disorder and doctors have been more discerning in admitting them.

“Most suspected cases are untested. Even if it is a lung infection caused by other agents, doctors cannot rule out a diagnosis (of the coronavirus). There are many people admitted and we don’t have tests. So the doctors lack assurance and end up hospitalizing more, because Covid-19 evolves very fast,” he explains.

Testing has no influence on the care of people with Covid-19. In the absence of proven drugs to treat the disease, the doctors’ job is basically to assist the patient with difficulties in more severe cases (with ventilators and intubation) until he or she regains breathing ability.

Coronavirus admissions specifically in ICUs may last three times longer than admissions for other flus. The concern is that the health system, already experiencing high demand, will collapse. This means that even with the resources, it will not be able to attend a great demand of patients.

Thus the significance of social isolation, since it can flatten the curve of the disease by spreading out the number of infections over a longer period of time, as stressed by Minister Luiz Henrique Mandetta on Monday. He says the Ministry of Health is working to expand the SUS (National Health Service) capacity to meet the new demand.

“The virus is attacking the world health systems. It is more dramatic than major wars,” he said.

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.